
    
      Fifty (50) subjects, 18 years of age and older, will be implanted across the United States
      and Canada. Subjects with moderate to profound bilateral sensorineural hearing loss will be
      implanted with the MED-EL SYNCHRONY/SYNCHRONY PIN Cochlear Implant System. .

      Limited benefit from amplification is defined by test scores of 60% correct or less in the
      ear to be implanted (70% or less in the nonimplanted ear) on monosyllabic words in quiet.
      Subjects will be followed for twelve (12) months post-activation of the SONNETEAS Audio
      Processor.
    
  